Bu çalışmamızda Abdomino-permeal rezeksiyon (Mile operasyonu) uygulanan 70 rektum kanserli olguda yaş, histopatolojik sınıflama, adjuvan kemo-radyoterapi uygulanması ve ortalama takip süreleri irdelenmdi. Materyal ve Metod: Kliniğimize 1988-1995 yılları arasında buşvuran 70 rektum kanserli olgunun hepsine Mile operasyonu uygulanmış olup hastalara postoperatif dönemde kemo-radyoterapi verilmiştir. Bulgular retrospektif olarak analiz edildi. Bulgular : 70 olgumuzda erkek-kadın oranı (35/35) eşitti. Median yaş 55 (17-83 yaş) idi. Adenokarsinom 50 olguda (%71.4), müsinöz adeno karsinom 13 olguda (%18.5), papiller adeno karsinom 1 olguda (%1.4), taşlı yüzük hücreli karsinom 1 olguda (%1.4), malign melanom 3 olguda (%4.2), non-keratinize epidermoid karsinom 1 olguda (%1.4), indiferansiye malign tümör 1 olguda (%1.4) bulunmuştur. Sonuç: 70 olgudan 40 olgu 6 ay ve üzeri takip edildi, bu 40 olgunun ortalama takip süreleri 23.1 ay (6-60 ay) idi. Kemoterapi ve radyoterapi uygulanan olgularda ortalama takip süresi daha uzun bulunmuştur (26.1 ay).
We retrospectively the reviewed age, histopathologic classification, adjuvant chemoradiotherapy, and mean follow-up periods in 70 patients with rectum cancer who underwent abdomino-perineal resection (Mile's operation). Materials and Methods: A total of 70 patients with rectum cancer admitted to our clinics between 1988 and 1995, all of whom underwent Mile's operation. All patients received chemoradiotherapy during the postoperative period. Results: There were 35 males and 35 females, with mean age being 55 years (range 17-83 years). Tumors included; adenocarcinoma in 50 (71.4%), mucinous adenocarcinoma in 13 (18.5%), papillary adenocarcinoma in 1 (1.4%), signet-ring cell carcinoma in 1 (1.4%), malignant melanoma in 3 (4.2%), non-karatinized epidermoid carcinoma in 1 (1.4%), and indifferentiated malignant tumor in 1 (1.4%). Conclusion: Forty patients were followed-up for six months or more. Mean follow-up period was 23.1 months (range 6-60 months). In patients receiving chemotherapy and radiotherapy, follow-up period was found to be longer (26.1 months).
